OHSU, VA Portland Study Links Agent Orange to Parkinson's Disease

Oregon Health & Science University
Veterans who directly handled the chemical in the Vietnam War are 99% more likely to develop Parkinson's; highlights long-term health risks of chemical exposure

Vietnam War-era military veterans exposed to Agent Orange have a 57% greater risk of developing Parkinson's and related diseases compared with those who weren't exposed, according to new research that examined electronic health records covering millions of veterans.

The study, led by researchers with Oregon Health & Science University and the VA Portland Health Care System, published today in the journal JAMA Neurology.

Clinicians and veterans had long presumed a correlation between neurodegenerative conditions, including Parkinson's, and exposure to the chemical defoliant used by the American military during the Vietnam War, the researchers said.

The new study definitively draws the link, using a vast electronic database of health records across decades.

Lee Neilson, M.D. has short brown hair, a white coat, and smiling.
Lee Neilson, M.D. (OHSU)

"Veterans have been talking about this for years and years," said co-author Lee Neilson, M.D., a neurologist formerly with OHSU and now with the University of Iowa Health Care. "I expect they will feel validated and heard with this study."

Neilson started the research project with colleagues in his previous capacity with OHSU.

Researchers examined electronic health records encompassing 4.9 million veterans who served during the Vietnam War era. They homed in on conditions that would appear decades later, from 1999 to 2022, looking for an association between the level of exposure to Agent Orange and subsequent diagnoses of Parkinson's disease and the related disorder known as Lewy body dementia. They adjusted for confounding factors such as traumatic brain injury and frailty.

They found veterans with possible or presumed exposure to Agent Orange were 44% more likely to develop Parkinson's and 66% more likely to develop Lewy body dementia compared with those who weren't exposed to the herbicide. Veterans with higher exposure through direct handling and spraying were 99% more likely to develop Parkinson's.

Overall, the study found exposure associated with a 57% greater risk of the two related neurodegenerative conditions.

Gregory has short gray hair and is wearing eyeglasses and a plaid shirt.
Gregory D. Scott, M.D., Ph.D. (OHSU)

"This is the first study in veterans to identify that increased risk of Parkinson's is associated with heavier exposure to Agent Orange," said co-senior author Gregory Scott, M.D., Ph.D., associate professor of pathology in the OHSU School of Medicine and a pathologist at the VA Portland. "We're catching up with history in a way."

The study found heightened risks among veterans who directly sprayed or handled Agent Orange as members of the Army Chemical Corps and Operation Air Force Ranch Hand.

Shereef has shaved hair, smiling in a garden, wearing a gray suit.
Shereef Elnahal, M.D., M.B.A. (OHSU)

OHSU President Shereef Elnahal, M.D., M.B.A., who previously served as undersecretary of health in the U.S. Department of Veterans Affairs, noted that the PACT Act of 2022 rightly extended healthcare benefits to military veterans exposed to toxic substances like Agent Orange, removing the burden of proof for veterans trying to access care. This new research reinforces why that was so important.

"This research offers critical insight for veterans who may have been diagnosed with Parkinson's even decades after their exposure to Agent Orange in Southeast Asia," Elnahal said. "Veterans who put themselves in harm's way deserve to know the truth no matter how long it takes."

The study may validate the experience of veterans, but Scott said it should also raise awareness about the long-term health risks of prolonged exposure to other chemical pesticides and herbicides.

"I think this adds weight to the idea that we ought to get on top of this and not wait 50 years for the next herbicide to be linked to neurodegenerative disease," Scott said.

In addition to Neilson and Scott, co-authors included Miranda Lim, M.D., Ph.D., and Jonathan Elliott, Ph.D., of OHSU and the VA Portland Health Care System. Lim also is affiliated with the Oregon Institute of Occupational Health Sciences at OHSU.

The research was supported by the U.S. Department of Veterans Affairs, awards BLRD CDA2 BX005760, 357 CSRD CDA2 CX00253, RRD Merit Awards RX004822 and RX005371, CSRD Merit Award CX002022 and BLRD Merit Award BX006155; the John and Tami Marick Family Foundation; the Collins Medical 356 Trust Award, the OHSU MRF New Investigator Award; the Parkinson's Center of Oregon Pilot Award; The Department of Defense awards CDMRP PRP #HT9425-24-1-0774 358 and #HT9425-24-1-0775; the National Institute on Aging of the National Institutes of Health award P30AG066518; and the Military Exposures Research Program supplement to BLRD Merit Award Supplement 360 BX006155. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, the VA, the DOD or other funders.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.